真人做爰48姿势视图片|少妇真人直播免费视频|日本真人做爰A片|真人裸体做爰视频|真人与拘做爰视频免费观看|真人与拘做受免费视频一

尿激酶型纖溶酶原激活因子受體(uPAR)活性蛋白

Active Plasminogen Activator, Urokinase Receptor (uPAR)

CD87; PLAUR; PLAU-R; U-PAR; URKR; Monocyte Activation Antigen Mo3

  • 尿激酶型纖溶酶原激活因子受體(uPAR)活性蛋白 產(chǎn)品包裝(模擬)
  • 尿激酶型纖溶酶原激活因子受體(uPAR)活性蛋白 產(chǎn)品包裝(模擬)
  • APA141Ra01.jpg Figure. SDS-PAGE
  • Certificate 通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證

活性實(shí)驗(yàn)

Plasminogen Activator, Urokinase Receptor (uPAR) is the receptor for urokinase plasminogen activator and, given its role in localizing and promoting plasmin formation, likely influences many normal and pathological processes related to cell-surface plasminogen activation and localized degradation of the extracellular matrix. The urokinase receptor (uPAR) was identified as the membrane receptor of the serine protease urokinase (uPA), thereby implicated in the plasminogen activation cascade and regulation of pericellular proteolysis, thus a binding ELISA assay was conducted to detect the interaction of recombinant rat uPAR and recombinant human uPA. Briefly, biotin-linked uPAR were diluted serially in PBS, with 0.01% BSA (pH 7.4). Duplicate samples of 100 ul were then transferred to uPA-coated microtiter wells and incubated for 1h at 37 ℃. Wells were washed with PBST 3 times and incubation with Streptavidin-HRP for 30min, then wells were aspirated and washed 5 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37 ℃. Finally, add 50 μl stop solution to the wells and read at 450 nm immediately. The binding activity of uPAR and uPA was shown in Figure 1, the EC50?for this effect is 0.223 ug/mL.

用法

Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

儲存

避免反復(fù)凍融。2-8°C不超過一個月,-80°C不超過12個月。

穩(wěn)定性

熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲,損失率低于5%。

相關(guān)產(chǎn)品

編號 適用物種:Rattus norvegicus (Rat,大鼠) 應(yīng)用(僅供研究使用,不用于臨床診斷!)
RPA141Ra01 尿激酶型纖溶酶原激活因子受體(uPAR)重組蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
APA141Ra01 尿激酶型纖溶酶原激活因子受體(uPAR)活性蛋白 Cell?culture;?Activity?Assays.
PAA141Ra01 尿激酶型纖溶酶原激活因子受體(uPAR)多克隆抗體 WB; IHC; ICC; IP.
LAA141Ra71 尿激酶型纖溶酶原激活因子受體(uPAR)多克隆抗體(生物素標(biāo)記) WB; IHC; ICC.
MAA141Ra23 尿激酶型纖溶酶原激活因子受體(uPAR)單克隆抗體 WB; IHC; ICC; IP.
MAA141Ra21 尿激酶型纖溶酶原激活因子受體(uPAR)單克隆抗體 WB; IHC; ICC; IP.
MAA141Ra22 尿激酶型纖溶酶原激活因子受體(uPAR)單克隆抗體 WB; IHC; ICC; IP.
SEA141Ra 尿激酶型纖溶酶原激活因子受體(uPAR)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA141Ra 尿激酶型纖溶酶原激活因子受體(uPAR)等多因子檢測試劑盒(流式熒光發(fā)光法) FLIA Kit for Antigen Detection.

參考文獻(xiàn)

雜志 參考文獻(xiàn)
International Journal of Cancer Dietary supplementation with methylseleninic acid, but not selenomethionine, reduces spontaneous metastasis of Lewis lung carcinoma in mice [Wiley: source]
Biomark Insights Decreased Epidermal Growth Factor (EGF) Associated with HMGB1 and Increased Hyperactivity in Children with Autism [PubMed: PMC3623607]
Biomarker insights Decreased Hepatocyte Growth Factor (HGF) and Gamma Aminobutyric Acid (GABA) in Individuals with Obsessive-Compulsive Disorder (OCD) [PubMed: PMC3762604]
Am J Emerg Med Clinical value of soluble urokinase-type plasminogen activator receptor in the diagnosis, prognosis, and therapeutic guidance of sepsis [PubMed: 26615223]
Archives of Clinical Infectious Diseases Evaluation of Diagnostic Value of Soluble Urokinase-Type Plasminogen Activator Receptor in Sepsis [Archcid: 26346]
The American Journal of Emergency Medicine Clinical value of soluble urokinase-type plasminogen activator receptor in the diagnosis, prognosis, and therapeutic Cavia (Guinea pig )idance of sepsis [science:S0735675715009559]
Journal of Clinical and Experimental Hepatology Evaluation of Plasma Urokinase-Type Plasminogen Activator Receptor (UPAR) in Patients With Chronic Hepatitis B, C and Non-Alcoholic Fatty Liver Disease (NAFLD)?… [10.1016:j.jceh.2018.02.001]
Turkish journal of trauma & emergency surgery The diagnostic value of serum urokinase-type plasminogen activator receptor in acute appendicitis [Pubmed: 31475329]
CELL TRANSPLANTATION Predictive Value of Degranulating Factors of Neutrophils in Massive Cerebral Infarction [33787356]
留言咨詢
湟源县| 策勒县| 旬邑县| 沈阳市| 西吉县| 肥东县| 广德县| 叙永县| 淅川县| 盐城市| 溆浦县| 武安市| 紫金县| 镇雄县| 新河县| 吕梁市| 榕江县| 吴旗县| 西乌珠穆沁旗| 广德县| 石阡县| 延津县| 临武县| 建平县| 滨海县| 镇雄县| 天门市| 咸丰县| 绍兴市| 磐石市| 禄丰县| 新兴县| 苏尼特右旗| 永新县| 长治县| 金山区| 贺州市| 庆安县| 紫阳县| 怀安县| 嵊泗县|